
Jess E. Maxwell, M.D., M.B.A.
Department of Surgical Oncology, Division of Surgery
Education & Training
Degree-Granting Education
2011 | University of Iowa Carver College of Medicine, Iowa City, IA, USA, MD, Doctor of Medicine |
2011 | University of Iowa Tippie School of Management, Iowa City, IA, USA, MBA, Masters of Business Administration |
2004 | University of Wisconsin, Madison, WI, USA, BS, Bachelors of Science |
Postgraduate Training
2020-2020 | Intensive Seminar, Value-Based Health Care Delivery, Harvard Business School, Boston, MA |
2018-2020 | Clinical Fellowship, Complex General Surgical Oncology, MD Anderson Cancer Center, Houston, TX |
2017-2018 | Administrative Chief Resident, University of Iowa Carver College of Medicine, Iowa City, IA |
2013-2015 | Research Fellowship, NIH Research Fellowship (T32), University of Iowa Carver College of Medicine, Iowa City, IA |
2012-2018 | Clinical Residency, Resident in General Surgery, University of Iowa Carver College of Medicine, Iowa City, IA |
2011-2012 | Clinical Internship, Resident in General Surgery, University of Iowa Carver College, Iowa City, IA |
Board Certifications
2022 | American Board of Surgery - Complex General Surgical Oncology |
2019 | American Board of Surgery - General Surgery |
Experience & Service
Academic Appointments
Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Other Appointments/Responsibilities
Research Specialist - AIDS Vaccine Research Library, University of Wisconsin, Madison, WI, 2004 - 2006
Honors & Awards
2019 | MDA Awesome Job Award, UT MD Anderson Award |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Pieterman CRC, Sadowski SM, Maxwell JE, Katz MHG, Lines KE, Heaphy CM, Tirosh A, Blau JE, Perrier ND, Lewis MA, Metzcar JP, Halperin DM, Thakker RV, Valk GD.. MEN1-related pancreatic NETs: Identification of unmet clinical needs and future directives. Endocrine-Related Cancer, 2020.
- Maxwell JE, Gule-Monroe MK, Subbiah V, Hu M, Perrier ND, Cabanillas ME, Lee JE, Graham, Cote GJ, Busaidy NL, Grubbs EG.. Novel use of a CLIA-certified CDKN2C Loss Assay in Sporadic Medullary Thyroid Carcinoma. Surgery, 2020.
- Scott AT, Pelletier D, Maxwell JE, Sherman SK, Keck KJ, Li G, Dillon JS, O’Dorisio TM, Bellizzi AM, Howe JR.. The Pancreas is a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors. Clinical and Experimental Metastasis, 2018.
- Hoshi H, Zaheer A, El Abiad RG, Maxwell JE, Chu LC, Gerke H, Chan CH.. Management of Pancreatic Intraductal Papillary Mucinous Neoplasm. Curr Probl Surg, 2018.
- Keck KJ, Maxwell JE, Utria AF, Bellizzi AM, Dillon JS, O’Dorisio TM, Howe JR. The Distal Predilection of Small Bowel Neuroendocrine Tumors. Ann Surg Oncol, 2018.
- Czeczok TW, Stashek KM, Maxwell JE, O’Dorisio TM, Howe JR, Hornick JL, Bellizzi AM.. Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-Differentiated Tumor Suggests a Jejunoileal Origin. Appl Immunohistochem Mol Morphol, 2018.
- Maxwell JE*, Choi AB*, Keck KJ, Bellizzi AM, Dillon JS, O’Dorisio TM, Howe JR. Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?. Pancreas, 2017.
- Keck KJ, Choi AB, Maxwell JE, Li G, O’Dorisio TM, Breheny P, Bellizzi AM, Howe JR.. Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival. Ann Surg Oncol, 2017.
- Keck KJ, Maxwell JE, Menda Y, Bellizzi AM, Dillon J, O’Dorisio TM, Howe JR. Identification of Primary Tumors in Patients Presenting with Metastatic Gastroenteropancreatic Neuroendocrine Tumors. Surgery, 2017.
- Maxwell JE, Sherman SK, Howe JR.. Translational Diagnostics and Therapeutics in Pancreatic Neuroendocrine Tumors. Clinical Cancer Res 22(20):5022–9, 2016.
- Maxwell JE, O’Dorisio TM, Howe JR. Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am 25(1):171-94, 2016.
- Maxwell JE, Sherman SK, O’Dorisio TM, Bellizzi AM, Howe JR.. Liver-Directed Surgery of Neuroendocrine Metastases: What is The Optimal Strategy?. Surgery 159(1):320-33, 2016.
- Maxwell JE, Howe JR. Imaging in NETs: an Update for Clinician. Int J Endocr Oncol(2(2):159-168), 2015.
- Maxwell JE, Sherman SK, Li G, Choi AB, Bellizzi AM, O’Dorisio TM, Howe JR. Somatic Alterations of CDKN1B are Associated with Small Bowel Neuroendocrine Tumors. Cancer Genet, 2015.
- Maxwell JE, Sherman SK, Menda Y, Wang D, O’Dorisio TM, Howe JR. Limitations of Somatostatin Scintigraphy in Primary Small Bowel NETs. J Surg Res 190(2):548-53, 2014.
- Maxwell JE, Sherman SK, Stashek KM, O’Dorisio TM, Bellizzi AM, Howe JR.. A Practical Method to Determine the Site of Unknown Primary in Metastatic Neuroendocrine Tumors. Surgery 156(6):1359-65, 2014.
- Maxwell JE, Sherman SK, O’Dorisio, TM, Howe JR. Medical Management of Medullary Thyroid Cancer. Cancer 120(21):3287-301, 2014.
- Sherman SK, Maxwell JE, O’Dorisio TM, Howe JR.. Pancreastatin Predicts Survival In Neuroendocrine Tumors. Ann Surg Oncol 21(9):2971-80, 2014.
- Maxwell JE, O’Dorisio TM, Bellizzi AM, Howe JR.. Elevated Pancreatic Polypeptide Levels in Pancreatic Neuroendocrine Tumors and Diabetes Mellitus: Causation or Association?. Pancreas 43(4):651-6, 2014.
- Sherman SK, Maxwell JE, Carr JC, Wang D, O’Dorisio SM, O’Dorisio TM, Howe JR. GIPR Expression in Gastric and Duodenal Neuroendocrine Tumors. J Surg Res 190(2):587-93, 2014.
- Sherman SK, Maxwell JE, Carr JC, Wang D, Bellizzi AM, O’Dorisio MS, O’Dorisio TM, Howe JR. Gene Expression Accurately Distinguishes Liver Metastases of Small Bowel and Pancreas Neuroendocrine Tumors. Clin Exp Metastasis 31(8):935-44, 2014.
- Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI. Mamu-B*08- positive Macaques Control Simian Immunodeficiency Virus Replication. J Virol 81(16):8827-32, 2007.